Answers are grounded in this paper and cite their sources.
Assesses PLP-1 IgG as a prognostic biomarker in MOGAD, indicating its potential clinical use.
We aimed to assess the potential of Proteolipid Protein 1 (PLP1)-IgG as a prognostic biomarker in a large multicentric MOGAD cohort.
No takes yet. Share an insight, caveat, or question.
Greco et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: